期刊文献+

Inactivation of bovine immunodeficiency virus by photodynamic therapy with HMME

Inactivation of bovine immunodeficiency virus by photodynamic therapy with HMME
原文传递
导出
摘要 To investigate the effect of photodynamic therapy (PDT) with hematoporphrin monomethyl ether (HMME) on bovine immunodeficiency virus (BIV) can provide the basis theory for photoinactivation of human immunodeficiency virus (HIV). To assess the protection of HMME-PDT on the cell line Cf2Th infected with BIVR29 by 3-(4,5)-dimethylthiahiazol-2-yl-3,5-di-phenytetrazolium bromide (MTT) with power density of 5 and 25 mW/cm^2 and energy density from 0.6 to 3 J/cm^2. To observe the inhibition of membrane fusion using a new reporter cell line BIVE by fluorescence microscope. HMME-PDT has significant protectant effects on Cf2Th-BIVR29 with both power densities, especially in the group of high power density. Fluorescent microscope shows that there is no significant difference between the group of PDT and control, which means PDT could not inhibit the BIV-mediated membrane fusion. To investigate the effect of photodynamic therapy (PDT) with hematoporphrin monomethyl ether (HMME) on bovine immunodeficiency virus (BIV) can provide the basis theory for photoinactivation of human immunodeficiency virus (HIV). To assess the protection of HMME-PDT on the cell line Cf2Th infected with BIVR29 by 3-(4,5)-dimethylthiahiazol-2-yl-3,5-di-phenytetrazolium bromide (MTT) with power density of 5 and 25 mW/cm^2 and energy density from 0.6 to 3 J/cm^2. To observe the inhibition of membrane fusion using a new reporter cell line BIVE by fluorescence microscope. HMME-PDT has significant protectant effects on Cf2Th-BIVR29 with both power densities, especially in the group of high power density. Fluorescent microscope shows that there is no significant difference between the group of PDT and control, which means PDT could not inhibit the BIV-mediated membrane fusion.
出处 《Chinese Optics Letters》 SCIE EI CAS CSCD 2008年第12期944-946,共3页 中国光学快报(英文版)
基金 supported by the National Natural Science Foundation of China(No.60678047) the Science Foundation of Tianjin(No.05YFJZJC02300)
关键词 HMME BIV AIDS
  • 相关文献

参考文献1

二级参考文献35

  • 1[1]Berry N,Ariyoshi K,Balfe P,et al.2001.Sequence specificity of the human immunodeficiency virus type 2(hiv-2) long terminal repeat u3 region in vivo allows subtyping of the principal hiv-2 viral subtypes a and b.AIDS Res Hum Retroviruses,17:263-267.
  • 2[2]Carr J K,Salminen M O,Albert J,et al.1998.Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants.Virology,247:22-31.
  • 3[3]Charneau P,Borman A M,Quillent C,et al.1994.Isolation and envelope sequence of a highly divergent HIV-1 isolate:definition of a new HIV-1 group.Virology,205:247-253.
  • 4[4]Damond F,Worobey M,Campa P,et al.2004.Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification.AIDS Res Hum Retroviruses,20:666-672.
  • 5[5]Esparza J,Bhamarapravati N.2000.Accelerating the development and future availability of HIV-1 vaccines:why,when,where,and how? Lancet,355:2061-2066.
  • 6[6]Grez M,Dietrich U,Balfe P,et al.1994.Genetic analysis of human immunodeficiency virus type 1 and 2 (HIV-1 and HIV-2) mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from a single ancestor for each of these viruses.J Virol,68:2161-2168.
  • 7[7]Gurtler L G,Hauser P H,Eberle J,et al.1994.A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon.J Virol,68:1581-1585.
  • 8[8]Kalish M L,Baldwin A,Raktham S,et al.1995.The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok,Thailand:implications for HIV vaccine trials.AIDS,9:851-857.
  • 9[9].Kim S S,Kim E Y,Park K Y,et al.2000.Introduction of human immunodeficiency virus 2 infection into South Korea.Acta Virol,44:15-22.
  • 10[10]Kusagawa S,Imamura Y,Yasuoka A,et al.2003.Identification of HIN type 2 subtype B transmission in East Africa.AIDS Res Hum Retroviruses,19:1045-1049.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部